Medical office building space in Jacksonville, Fla., is rapidly shrinking in comparison to tenant needs, according to a Sept. 30 report from the Jacksonville Business Journal.
Category: Becker’s ASC Review
3 strategies for avoiding malpractice suits
There are several proactive strategies physicians can take to safeguard from the rise in malpractice suits, Medical Economics reported Oct. 1.
September payer updates: 5 things to know
Here are five payer moves in September for ASCs to know, as reported by Becker’s:
The 5 most expensive ASCs in September
Here are the five most expensive ASC projects in September, as reported by Becker’s:
Newark Beth Israel Medical Center, cardiologist accused of negligence following failed heart transplant
The sister of a patient who died following a failed heart transplant at Newark (N.J.) Beth Israel Medical Center is suing the hospital and the cardiologist claiming negligence.
10 hospital closures in Q3
Becker’s reported on 10 hospital closures in the third financial quarter of this year, and this shift may lead to an increase in volume for ASCs, as patients seek alternatives after losing access to services previously offered at hospitals.
Court declares qui tam whistleblower provisions unconstitutional in Florida practice's fraud case
A federal judge in Florida has dismissed a whistleblower lawsuit accusing a medical practice of inflating Medicare reimbursements, citing constitutional concerns over the False Claims Act’s qui tam provisions, law.com reported Oct. 4.
PeaceHealth to acquire 4 Providence medical clinics
Vancouver, Wash.-based PeaceHealth is planning to acquire four medical clinics from Renton, Wash.-based Providence, according to an Oct. 3 report from The Columbian.
Illinois system seeks approval for $50M ASC
HSHS St. Elizabeth’s Hospital is seeking approval for a $50 million expansion at its O’Fallon, Ill.-based medical campus, according to an Oct. 4 report from the Belleville News-Democrat.
Next-generation CRC test earns FDA approval
The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer.
